<DOC>
	<DOC>NCT01429207</DOC>
	<brief_summary>The purpose of the study is to test whether body-worn wireless motion sensors can measure dyskinesias (involuntary movements caused by medications) in individuals with Parkinson disease (PD) independent of voluntary activity being performed and other PD motor symptoms (e.g. tremor).</brief_summary>
	<brief_title>Capturing Parkinson's Disease Medication Side Effects During Daily Activities</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Clinical diagnosis of probable or definite idiopathic Parkinson Disease with motor fluctuations that include dyskinesias after taking their usual dose of levodopa/carbidopa Antipsychotic medications (including quetiapine and clozapine) Coexisting neurologic disease such as stroke or dementia Lacking capacity for informed consent Residing in a nursing home comorbid nonneurologic illnesses that impacts the ability to perform the study tasks Implantable defibrillators</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>levodopa</keyword>
	<keyword>tremor</keyword>
	<keyword>bradykinesia</keyword>
	<keyword>motion sensors</keyword>
</DOC>